A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: mistake (35), fault (22), slip (31)

Carboplatin(AUC5)-Paclitaxel_7day

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC 5)-PACLITAXEL(7 day) Regimen • Breast-Carboplatin (AUC 5)-Paclitaxel (7 day) Indication • Neo-adjuvant
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CarboplatinAUC5-Paclitaxel-7day.pdf

Azacitidine Oral

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine as maintenance therapy in newly diagnosed AML
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

BV-CHP Brentuximab vedotin-cyclophosphamide-doxorubicin-prednisolone Ver1

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE (BV-CHP) Regimen • Lymphoma – Brentuximab vedotin-cyclophosphamide-doxorubicin-prednisolone Indication Brentuximab vedotin in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BV-CHP-Brentuximab-vedotin-cyclophosphamide-doxorubicin-prednisolone.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (accelerated) Indication • Neoadjuvant / adjuvant therapy of early breast
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

Capecitabine-Trastuzumab-SC-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine– Trastuzumab (SC)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (SC)-Tucatinib Indication • Treatment of over-expressed HER2
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-SC-Tucatinib.pdf

Neratinib

Description
Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hormone receptor positive HER2overexpressed early
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Axicel-Cyclophosphamide(500)-Fludarabine(30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AXICEL – CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) This regimen will only be available
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Axicel-Cyclophosphamide500-Fludarabine30.pdf

Carboplatin(AUC6)Docetaxel

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel Indication • Neo-adjuvant or adjuvant treatment of triple
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CarboplatinAUC6Docetaxel.pdf

InP-LEAM

Description
Chemotherapy Protocol LYMPHOMA LOMUSTINE-CYTARABINE-ETOPOSIDE (split)-MELPHALAN (LEAM) Inpatient Regimen Regimen Lymphoma – InP-LEAM (split)-Lomustine-Cytarabine-Etoposide-Melphalan Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-LEAM.pdf

mini-RCHOP 21

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE (mini-RCHOP 21) Regimen   Lymphoma – mini-RCHOP (21)-Cyclophosphamide-Doxorubicin-PrednisoloneRituximab-Vincristine Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/mini-RCHOP-21.pdf
321 to 330 of 630
Previous … 31 32 33 34 35 … Next